News and Events

Vibiosphen is proud to be part of a growing ecosystem, we will be pleased to meet you at these events

Vibiosphen at GAMRIC 2026: Advancing Preclinical Research Against Antimicrobial Resistance

Vibiosphen is pleased to announce its participation in GAMRIC 2026, bringing together scientists, clinicians, biotechnology companies, pharmaceutical developers and other stakeholders committed to addressing one of the most pressing challenges in infectious diseases: antimicrobial resistance (AMR). Robin Dumas will represent Vibiosphen during the event, providing an opportunity to meet with teams developing new antimicrobial therapies and discuss how relevant preclinical strategies can help accelerate their development.

NYSCC Suppliers’ Day 2026

Come meet Robin DUMAS at NYSCC Suppliers’ Day! 🗽 Our Business Innovation Manager will be at booth 2379 on the 3rd floor and would love to discuss your projects with you! Will you be there? Let’s connect and talk microbiology!

Microbiome en Occitanie

We will be participating in the event “Microbiome en Occitanie” in Narbonne on April 16 and 17. On this occasion, our Scientific Director, Patricia Martin, will have the honor of presenting Vibiosphen’s contribution to innovations in this field of research during her presentation titled: “Skin Microbiome – Experimental Models for the Study of Dermo-Cosmetic Interventions.”

8th edition Bacteriophage Therapy Summit 2026

We are pleased to announce that Robin DUMAS is participating this week in the 8th Bacteriophage Therapy Summit in London

Meet us at Cosmetotest

Vibiosphen is exhibiting at the Cosmetotest on March 18-19, in Lyon. Come visit Robin DUMAS and Marine AVERSENG at our booth #22 to discuss your preclinical needs and discover our latest testing solutions for the cosmetics industry !

Join us at booth n°1 - AMR conference

We are thrilled to be exhibiting at the AMR Conference in Basel! Come and meet us at Booth n°1 and let’s explore how we can support your next antimicrobial program. 👉 Join us at the AMR Conference

Vibiosphen will be attending 9th AMR conference

We are thrilled to announce that Vibiosphen will be participating in the 9th AMR Conference! This event is a fantastic opportunity for us to connect with industry professionals, showcase our latest innovations, and engage in meaningful discussions about the future of our field.

Join Us at the 7th Bacteriophage Therapy Summit!

We are excited to announce that Vibiosphen will be participating in the 7th Bacteriophage Therapy Summit, taking place from March 11 to 13, 2025, in Boston, MA. This event is a premier gathering for industry leaders, researchers, and innovators in the field of bacteriophage therapy. We look forward to connecting with you at this important event to discuss our latest advancements and contributions to the fight against antibiotic resistance with effective and sustainable phage-based therapies.

Participating to the BIO US 2023 conference

We are very proud to share that Vibiosphen will be participating to BIO US 2023 in Boston the first week of June. We will be pleased to discover all the innovative projects in many fields.

Alternative technologies and models (NAMs) to Reduce the use of laboratory animals in Industry

Vibiosphen is attending and presenting at the Adebiotech event : Alternative technologies and models (NAMs) to Reduce the use of laboratory animals in Industry. Patricia Martin (CSO of Vibiosphen) will be presenting our model innovation in respiratory disease : the apical out lung organoids.

ECCMID 2023

Vibiosphen will be attending #ECCMID2023 in Copenhagen from 15th to 18th of April. We are excited to discover all the great science being done in the field of antimicrobials. We will be pleased to talk about your project / science and to discuss how to push it one step forward in the preclinical space.

Organ Modelling Congress

Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool

6th AMR Conference

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

Microbiome Movement Drug Development Europe

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Human - Animal One Health: At the Confluence of human & veterinary public health

Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both

AMR Innovation Mission Sweden 2022

The Mission aims to connect the Swedish AMR ecosystem to the international AMR ecosystem and vice versa.

Webinar : les membres AFSSI ont la parole

At the AFSSI webinar on May 25, 2021 at 3 p.m., Patricia Martin, CSO, will present Vibiosphen's innovative solutions.

Anti infectives drug development Webinar 21-22 April 2021

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater...

Virtual AMR Innovation Mission UK 2021

The AMR Innovation Mission UK 2021 aims to add to the global curbing of Antimicrobial resistance (AMR)...